MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.8433
-0.0282 (-3.24%)
At close: May 8, 2026, 4:00 PM EDT
0.8500
+0.0067 (0.79%)
After-hours: May 8, 2026, 7:09 PM EDT
MaxCyte Revenue
In the year 2025, MaxCyte had annual revenue of $33.03M, down -14.50%. MaxCyte had revenue of $7.30M in the quarter ending December 31, 2025, a decrease of -16.02%.
Revenue (ttm)
$33.03M
Revenue Growth
-14.50%
P/S Ratio
2.74
Revenue / Employee
$362,923
Employees
91
Market Cap
90.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 33.03M | -5.60M | -14.50% |
| Dec 31, 2024 | 38.63M | -2.66M | -6.44% |
| Dec 31, 2023 | 41.29M | -2.97M | -6.72% |
| Dec 31, 2022 | 44.26M | 10.37M | 30.59% |
| Dec 31, 2021 | 33.89M | 7.73M | 29.52% |
| Dec 31, 2020 | 26.17M | 4.55M | 21.04% |
| Dec 31, 2019 | 21.62M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Neuronetics | 151.64M |
| Xtant Medical Holdings | 133.93M |
| Outset Medical | 117.59M |
| AVITA Medical | 71.61M |
| LENSAR | 57.70M |
| Rapid Micro Biosystems | 33.59M |
| Spectral AI | 19.65M |
| QT Imaging Holdings | 18.93M |
MXCT News
- 10 days ago - MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026 - GlobeNewsWire
- 5 weeks ago - MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - MaxCyte price target lowered to $5 from $7 at Craig-Hallum - TheFly
- 6 weeks ago - MaxCyte Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - MaxCyte sees FY26 revenue $30M-$32M, consensus $38.41M - TheFly
- 6 weeks ago - MaxCyte reports Q4 EPS (9c), consensus (8c) - TheFly
- 6 weeks ago - MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance - GlobeNewsWire
- 6 weeks ago - MaxCyte appoints Parmeet Ahuja as CFO - TheFly